Ischemic stroke related to anabolic abuse

Clinical Neuropharmacology

Volumn 31, Issue 2, 2008, Pages 80-85

  Santamarina, Rodrigo Daniel ^a   Besocke, Ana Gabriela ^a   Romano, Lucas Martin ^a   Ioli, Pablo Leonardo ^a   Gonorazky, Sergio Eduardo ^a  

^a HOSPITAL PRIVADO DE COMUNIDAD   (Argentina)

Author keywords

Anabolic abuse; Anabolic androgenic steroids; Cerebrovascular accident; Ischemic stroke; Stanozolol; Substance related disorders

Indexed keywords

ANABOLIC AGENT; STANOZOLOL;

ADULT; ANGIOGRAPHY; ARTICLE; ATHLETE; BLOOD VESSEL TONE; CASE REPORT; CEREBROVASCULAR ACCIDENT; DRUG ABUSE; ECHOCARDIOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; RISK FACTOR; SUBSTANCE ABUSE; THROMBOCYTE AGGREGATION;

ADULT; ANABOLIC AGENTS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; STANOZOLOL; STROKE; SUBSTANCE-RELATED DISORDERS;

EID: 41749107171     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e3180ed4485     Document Type: Article

References (36)

1. Marini C, Totaro R, De Santis F, et al. Stroke in young adults in the community-based L'Aquila registry: incidence and prognosis. Stroke 2001;32(1):52-56.
2. Jacobs BS, Boden-Albala B, Lin IF, et al. Stroke in the young in the northern Manhattan stroke study. Stroke 2002;33(12):2789-2793.
3. Siqueira Neto JI, Santos AC, Fabio SR, et al. Cerebral infarction in patients aged 15 to 40 years. Stroke 1996;27(11):2016-2019.
4. Bogousslavsky J, Van Melle G, Regli F. The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke. Stroke 1988;19(9):1083-1092.
5. Lisiewicz J, Fijalkowski P, Sankowski J. Ischemic cerebral stroke and anabolic steroids (case report). Neurol Neurochir Pol 1999;32(suppl 6):137-139.
6. Frankle MA, Eichberg R, Zachariah SB. Anabolic androgenic steroids and a stroke in an athlete: case report. Arch Phys Med Rehabil 1988;69(8):632-633.
7. Akhter J, Hyder S, Ahmed M. Cerebrovascular accident associated with anabolic steroid use in a young man. Neurology 1994;44:2405-2406.
8. Laroche GP. Steroid anabolic drugs and arterial complications in an athlete - a case history. Angiology 1990;41(11):964-969.
9. Sheffer AL, Fearon DT, Austen KF. Hereditary angioedema: a decade of management with stanozolol. J Allergy Clin Immunol 1987;80(6):855-860.
10. Helfman T, Falanga V. Stanozolol as a novel therapeutic agent in dermatology. J Am Acad Dermatol 1995;33(2 pt 1):254-258.
11. Bahrke MS, Yesalis CE. Abuse of anabolic androgenic steroids and related substances in sport and exercise. Curr Opin Pharmacol 2004;4(6):614-620.
12. Roccella M, Paterno G, Bonanno M, et al. New addictions in the third millennium: anabolic steroids as a substance of abuse. Minerva Pediatr 2005;57(3):129-135.
13. Nagelberg SB, Laue L, Loriaux DL, et al. Cerebrovascular accident associated with testosterone therapy in a 21-year-old hypogonadal man. N Engl J Med 1986;314(10):649-650.
14. Shiozawa Z, Yamada H, Mabuchi C, et al. Superior sagittal sinus thrombosis associated with androgen therapy for hypoplastic anemia. Ann Neurol 1982;12(6):578-580.
15. Shiozawa Z, Tsunoda S, Noda A, et al. Cerebral hemorrhagic infarction associated with anabolic steroid therapy for hypoplastic anemia. Angiology 1986;37(10):725-730.
16. Godon P, Bonnefoy E, Guerard S, et al. Myocardial infarction and anabolic steroid use. A case report. Arch Mal Coeur Vaiss 2000;93(7):879-883.
17. Ferenchick GS, Schwartz D, Ball M, et al. Androgenic-anabolic steroid abuse and platelet aggregation: a pilot study in weight lifters. Am J Med Sci 1992;303(2):78-82.
18. Ferenchick GS. Anabolic/androgenic steroid abuse and thrombosis: is there a connection? Med Hypotheses 1991;35(1):27-31.
19. Glasser SP, Arnett DK, McVeigh GE, et al. Vascular compliance and cardiovascular disease: a risk factor or a marker? Am J Hypertens 1997;10(10 pt 1):1175-1189.
20. Lane HA, Grace F, Smith JC, et al. Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids. Eur J Clin Invest 2006;36(7):483-488.
21. Hartgens F, Rietjens G, Keizer HA, et al. Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a). Br J Sports Med 2004;38(3):253-259.
22. Kluft C, Preston FE, Malia R, et al. Stanozolol-induced changes in fibrinolysis and coagulation in healthy adults. Thromb Haemost 1984;51(2):157-164.
23. Sniderman AD, Marcovina SM. Apolipoprotein A1 and B. Clin Lab Med 2006;26(4):733-750.
24. Walldius G, Jungner I. The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy-a review of the evidence. J Intern Med 2006;259(5):493-519.
25. Olofsson SO, Boren J. Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis. J Intern Med 2005;258(5):395-410.
26. Winkler UH. Effects of androgens on haemostasis. Maturitas 1996;24(3):147-155.
27. Ferenchick GS, Hirokawa S, Mammen EF, et al. Anabolic-androgenic steroid abuse in weight lifters: evidence for activation of the hemostatic system. Am J Hematol 1995;49(4):282-288.
28. Halvorsen S, Thorsby PM, Haug E. Acute myocardial infarction in a young man who had been using androgenic anabolic steroids. Tidsskr Nor Laegeforen 2004;124(2):170-172.
29. Huie MJ. An acute myocardial infarction occurring in an anabolic steroid user. Med Sci Sports Exerc 1994;26(4):408-413.
30. Tischer KH, Heyny-von Haussen R, Mall G, et al. Coronary thrombosis and ectasia of coronary arteries after long-term use of anabolic steroids. Z Kardiol 2003;92(4):326-331.
31. Toyama M, Watanabe S, Kobayashi T, et al. Two cases of acute myocardial infarction associated with aplastic anemia during treatment with anabolic steroids. Jpn Heart J 1994;35(3):369-373.
32. Mewis C, Spyridopoulos I, Kuhlkamp V, et al. Manifestation of severe coronary heart disease after anabolic drug abuse. Clin Cardiol 1996;19(2):153-155.
33. Fineschi V, Baroldi G, Monciotti F, et al. Anabolic steroid abuse and cardiac sudden death. A pathologic study. Arch Pathol Lab Med 2001;125(2):253-255.
34. Ferenchick GS, Adelman S. Myocardial infarction associated with anabolic steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 1992;124(2):507-508.
35. Sullivan ML, Martinez CM, Gennis P, et al. The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis 1998;41(1):1-15.
36. Liu P, Death A, Handelsma DJ. Androgens and cardiovascular disease. Endocr Rev 2003;24(3):313-340.